We predicted that elevated plasma IL-6 levels would be related to greater depressive and negative symptom severity, particularly in individuals with early-stage schizophrenia, when the influence of antipsychotic medication and other illness-related confounders is less pronounced. Here, IL6 is linked to schizophrenia.